Advocates call for Ontario to make HIV prevention drugs free as cases climb

World AIDS Day is a crucial time for advocates to push for increased access to HIV prevention drugs in Ontario. Recent data has shown a concerning uptick in HIV cases in Canada, with a 35% increase in new diagnoses in 2023 compared to the previous year. This trend follows a 22% increase between 2021 and 2022, highlighting the ongoing reality of HIV in Canada.

Dr. Kevin Woodward, executive director of HQ Toronto, emphasized that despite decreased public awareness of the disease, HIV continues to affect individuals across the country. He believes that the pandemic may have contributed to the rise in cases due to reduced access to healthcare services. However, he also pointed out that the uptake of drugs like PrEP and PEP could significantly slow down transmission rates.

PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis) are highly effective medications that can drastically reduce the risk of HIV transmission when taken correctly. However, the cost of these drugs can be a barrier for many individuals, with PrEP costing around $250 per month for those without private insurance or access to provincial programs. Navigating government assistance programs can also be challenging for newcomers or individuals unfamiliar with the system.

In response to these challenges, NDP MPP Kristyn Wong-Tam has introduced a motion to have HIV prevention drugs covered under the Ontario Health Insurance Plan (OHIP). This initiative aims to make these medications accessible to all Ontarians free of charge, reducing barriers to prevention and treatment. Wong-Tam believes that the upfront investment in covering these drugs under OHIP will lead to long-term cost savings by preventing the need for expensive treatment programs.

Ian McKnight, director of programs and services for the Toronto People with AIDS Foundation, highlighted the difficulties faced by many clients, particularly newcomers and individuals experiencing homelessness. Accessing healthcare services and prevention options can be challenging for these vulnerable populations, further exacerbating the risk of HIV transmission.

Overall, increasing access to HIV prevention drugs through OHIP coverage is seen as a crucial step in combating the rising rates of HIV in Ontario. By removing financial barriers and improving access to these life-saving medications, advocates hope to make significant progress in reducing the transmission of HIV and supporting the health and well-being of all Ontarians.